O
XENT

OppenheimerFunds’s Intersect ENT, Inc XENT Stock Holding History

OppenheimerFunds’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$14.1M Buy
438,940
+8,938
+2% +$277K 0.02% 615
2018
Q4 		$12.1M Buy
430,002
+16,273
+4% +$477K 0.02% 628
2018
Q3 		$11.9M Buy
413,729
+14,584
+4% +$438K 0.01% 691
2018
Q2 		$14.9M Buy
+399,145
New +$15.7M 0.02% 652
2017
Q1 		– Sell
-563,989
Closed -$6.82M – 1905
2016
Q4 		$6.82M Buy
563,989
+23,493
+4% +$304K 0.01% 802
2016
Q3 		$8.56M Buy
+540,496
New +$8.14M 0.01% 758

Other funds holding XENT

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

OppenheimerFunds's XENT Position: Q1 2019 in Review

OppenheimerFunds increased its Intersect ENT, Inc (XENT) stake by 2.1% in Q1 2019, buying an estimated $277K and bringing the position to 438,940 shares worth $14.1M. The position accounts for 0.02% of the portfolio, ranked #615.

OppenheimerFunds first reported a position in XENT in Q3 2016 and has held it in 6 quarters since. The position peaked at $14.9M in Q2 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q1 2019.

  • OppenheimerFunds held 438,940 shares of Intersect ENT, Inc worth $14.1M as of Q1 2019.
  • OppenheimerFunds bought 8,938 Intersect ENT, Inc shares in Q1 2019, an estimated $277K.
  • Intersect ENT, Inc made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #615 holding.
  • OppenheimerFunds first reported a position in Intersect ENT, Inc in Q3 2016 and has held it in 6 quarters since.
  • OppenheimerFunds's Intersect ENT, Inc position peaked at $14.9M in Q2 2018.
  • 136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.